These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 23770230)
1. Lack of both α2-antiplasmin and plasminogen activator inhibitor type-1 induces high IgE production. Okada K; Ueshima S; Kawao N; Yano M; Tamura Y; Tanaka M; Sakamoto A; Hatano M; Arima M; Miyata S; Nagai N; Tokuhisa T; Matsuo O Life Sci; 2013 Jul; 93(2-3):89-95. PubMed ID: 23770230 [TBL] [Abstract][Full Text] [Related]
2. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1. Dewerchin M; Collen D; Lijnen HR Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016 [TBL] [Abstract][Full Text] [Related]
3. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667 [TBL] [Abstract][Full Text] [Related]
4. Critical role for white blood cell NAD(P)H oxidase-mediated plasminogen activator inhibitor-1 oxidation and ventricular rupture following acute myocardial infarction. Agarwal U; Zhou X; Weber K; Dadabayev AR; Penn MS J Mol Cell Cardiol; 2011 Mar; 50(3):426-32. PubMed ID: 20807543 [TBL] [Abstract][Full Text] [Related]
5. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice. Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014 [TBL] [Abstract][Full Text] [Related]
6. Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice. Tsujino T; Naito Y; Kawasaki D; Okuda S; Sakoda T; Fujioka Y; Sugaya T; Ohyanagi M Clin Exp Hypertens; 2005; 27(2-3):159-68. PubMed ID: 15835378 [TBL] [Abstract][Full Text] [Related]
7. The kidney is a major site of alpha(2)-antiplasmin production. Menoud PA; Sappino N; Boudal-Khoshbeen M; Vassalli JD; Sappino AP J Clin Invest; 1996 Jun; 97(11):2478-84. PubMed ID: 8647939 [TBL] [Abstract][Full Text] [Related]
8. Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding. Lijnen HR; Okada K; Matsuo O; Collen D; Dewerchin M Blood; 1999 Apr; 93(7):2274-81. PubMed ID: 10090937 [TBL] [Abstract][Full Text] [Related]
9. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice. Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464 [TBL] [Abstract][Full Text] [Related]
10. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis. Robbie LA; Booth NA; Croll AM; Bennett B Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139 [TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice. Schäfer K; Schroeter MR; Dellas C; Puls M; Nitsche M; Weiss E; Hasenfuss G; Konstantinides SV Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1254-9. PubMed ID: 16514083 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2. Perides G; Noring R; Klempner MS Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243 [TBL] [Abstract][Full Text] [Related]
13. Evidence for an active fibrinolytic system in normal human bone marrow. McWilliam NA; Robbie LA; Barelle CJ; Adey G; Prasad S; Bennett B; Booth NA Br J Haematol; 1996 Apr; 93(1):170-6. PubMed ID: 8611456 [TBL] [Abstract][Full Text] [Related]
14. Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha2-antiplasmin. Robbie LA; Bennett B; Keyt BA; Booth NA Br J Haematol; 2000 Nov; 111(2):517-23. PubMed ID: 11122093 [TBL] [Abstract][Full Text] [Related]
15. Decreased levels of PAI-1 and alpha 2-antiplasmin contribute to enhanced fibrinolytic activity in divers. Radziwon P; Olszański R; Tomaszewski R; Lipska A; Dabrowiecki Z; Korzeniewski K; Siermontowski P; Boczkowska-Radziwon B Thromb Res; 2007; 121(2):235-40. PubMed ID: 17521709 [TBL] [Abstract][Full Text] [Related]
16. The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha2-antiplasmin by reptilase, a thrombin-like venom enzyme. Urano T; Ihara H; Takada Y; Fujie M; Takada A Blood Coagul Fibrinolysis; 2000 Mar; 11(2):145-53. PubMed ID: 10759007 [TBL] [Abstract][Full Text] [Related]
17. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice. Kawasaki T; Dewerchin M; Lijnen HR; Vermylen J; Hoylaerts MF Blood; 2000 Jul; 96(1):153-60. PubMed ID: 10891445 [TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 controls bone marrow-derived cells therapeutic effect through MMP9 signaling: role in physiological and pathological wound healing. Ebrahimian TG; Squiban C; Roque T; Lugo-Martinez H; Hneino M; Buard V; Gourmelon P; Benderitter M; Milliat F; Tamarat R Stem Cells; 2012 Jul; 30(7):1436-46. PubMed ID: 22570200 [TBL] [Abstract][Full Text] [Related]
19. PAI-1 and α2-AP in patients with morbid obesity. Michalska M; Iwan-Ziętek I; Gniłka W; Dąbrowiecki S; Góralczyk B; Góralczyk K; Drela E; Rość D Adv Clin Exp Med; 2013; 22(6):801-7. PubMed ID: 24431308 [TBL] [Abstract][Full Text] [Related]